Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BI-2536 | FIMM | pan-cancer | AAC | 0.05 | 0.7 |
mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.7 |
mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |